NDC 61703-304

Cytarabine

Cytarabine

Cytarabine is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Cytarabine.

Product ID61703-304_7eb21af3-b7da-49c5-85f5-3de0dff448b9
NDC61703-304
Product TypeHuman Prescription Drug
Proprietary NameCytarabine
Generic NameCytarabine
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date1994-02-28
Marketing CategoryANDA / ANDA
Application NumberANDA072945
Labeler NameHospira, Inc.
Substance NameCYTARABINE
Active Ingredient Strength20 mg/mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 61703-304-36

1 VIAL, MULTI-DOSE in 1 CARTON (61703-304-36) > 25 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date1994-02-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61703-304-36 [61703030436]

Cytarabine INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA072945
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1994-02-28

Drug Details

Active Ingredients

IngredientStrength
CYTARABINE20 mg/mL

OpenFDA Data

SPL SET ID:21e8e8e6-3f85-4fdd-8452-c9d14d2ef69a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 240416
  • Pharmacological Class

    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]

    NDC Crossover Matching brand name "Cytarabine" or generic name "Cytarabine"

    NDCBrand NameGeneric Name
    61703-303CYTARABINECYTARABINE
    61703-304CytarabineCYTARABINE
    61703-305CytarabineCYTARABINE
    61703-319CytarabineCYTARABINE
    63323-120CytarabineCYTARABINE
    67457-452CytarabineCytarabine
    67457-454CytarabineCytarabine
    67457-455cytarabinecytarabine
    68083-337CytarabineCytarabine
    68083-343CytarabineCytarabine
    71288-108CytarabineCytarabine
    71288-109CytarabineCytarabine
    71288-168CytarabineCytarabine
    71288-169CytarabineCytarabine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.